Welcome to our dedicated page for Charles & Colvard news (Ticker: CTHR), a resource for investors and traders seeking the latest updates and insights on Charles & Colvard stock.
Charles & Colvard, Ltd. (CTHR) generates news that spans product strategy, financing, governance, and stock listing developments, reflecting its role as a fine jewelry company focused on moissanite and lab-grown diamonds. Company press releases emphasize its identity as the original creator of lab-grown moissanite and a promoter of Made, not Mined™ above-ground gemstones and recycled precious metals, while also documenting key events that matter to investors and industry observers.
News coverage for Charles & Colvard often highlights strategic partnerships and product-related initiatives. Examples include its alliance with Ethara Capital LLC, an affiliate of Bhanderi Lab Grown Diamonds Inc., to expand its Caydia® lab-grown diamond offerings for both consumers and wholesale markets, and its exclusive strategic alliance with the International Gemological Institute (IGI) to introduce grading reports for Forever One™ moissanite gemstones and jewelry. Another notable development is its partnership with VideoShops, a social commerce network, which brings the company’s Made, not Mined™ jewelry catalog into customer-run storefronts and peer-to-peer selling environments.
Investors following CTHR news will also see regulatory and capital markets updates. The company has reported on a one-for-ten reverse stock split intended to address Nasdaq’s minimum bid price requirement, subsequent notices of non-compliance related to delayed SEC filings, and an April 2025 announcement that Nasdaq would suspend trading and delist its common stock, with the company expecting quotation on the OTC Experts Market. Additional news includes arbitration outcomes, shareholder activism and proxy-related communications, and disclosures about financing agreements such as the Convertible Secured Note Purchase Agreement with Ethara Capital LLC.
This news page allows readers to track how Charles & Colvard’s branding around Forever One™ moissanite and Caydia® lab-grown diamonds intersects with governance changes, litigation, financing, and trading status updates. Regularly reviewing CTHR news can help market participants understand both the company’s jewelry-focused initiatives and the risks and structural changes described in its public statements.
Charles & Colvard (Nasdaq: CTHR), a renowned fine jewelry company, announced a one-for-ten (1:10) reverse stock split of its common stock. Effective May 17, 2024, this move aims to comply with Nasdaq’s $1.00 minimum bid price requirement. Post-split, the number of shares will reduce from approximately 30 million to 3 million, with no fractional shares issued. The company's ticker remains 'CTHR'. Shareholders approved the proposal on May 7, 2024, and the North Carolina Secretary of State filed the Articles of Amendment on May 14, 2024. The company’s stock options and equity awards will adjust proportionately.
Charles & Colvard, a fine jewelry company specializing in moissanite and lab-grown diamonds, reported third-quarter fiscal year 2024 financial results. Despite a challenging quarter, the company remains focused on growth through strategic initiatives and technology investments. They saw growth in repeat customers and positive responses to new products and marketing efforts. The company introduced new gemstone brands, expanded product lines, and partnered with a celebrity brand ambassador. However, they experienced a 21% decrease in net sales, primarily in the Traditional segment. Gross profit margin declined to 23%, and operating expenses increased by 13%. The net loss was $3.6 million for the quarter, with cash and inventory decreasing.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.